Evaluation of the Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution of Two Different Formulations of a Locally-acting Mometasone Furoate Suspension-based Nasal Spray
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Mometasone (Primary)
- Indications Hypersensitivity
- Focus Pharmacokinetics
- 01 Sep 2017 Planned number of patients changed from 100 to 50.
- 01 Sep 2017 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.
- 01 Sep 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Sep 2018.